Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

IL-1β inflammatory response driven by primary breast cancer prevents metastasis-initiating cell colonization.

Castaño Z, San Juan BP, Spiegel A, Pant A, DeCristo MJ, Laszewski T, Ubellacker JM, Janssen SR, Dongre A, Reinhardt F, Henderson A, Del Rio AG, Gifford AM, Herbert ZT, Hutchinson JN, Weinberg RA, Chaffer CL, McAllister SS.

Nat Cell Biol. 2018 Sep;20(9):1084-1097. doi: 10.1038/s41556-018-0173-5. Epub 2018 Aug 27.

PMID:
30154549
2.

Modulating Bone Marrow Hematopoietic Lineage Potential to Prevent Bone Metastasis in Breast Cancer.

Ubellacker JM, Baryawno N, Severe N, DeCristo MJ, Sceneay J, Hutchinson JN, Haider MT, Rhee CS, Qin Y, Gregory WM, Garrido-Castro AC, Holen I, Brown JE, Coleman RE, Scadden DT, McAllister SS.

Cancer Res. 2018 Sep 15;78(18):5300-5314. doi: 10.1158/0008-5472.CAN-18-0548. Epub 2018 Jul 31.

PMID:
30065048
3.

CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest.

Goel S, DeCristo MJ, McAllister SS, Zhao JJ.

Trends Cell Biol. 2018 Jul 27. pii: S0962-8924(18)30123-5. doi: 10.1016/j.tcb.2018.07.002. [Epub ahead of print] Review.

PMID:
30061045
4.

Inhibition of epithelial cell migration and Src/FAK signaling by SIRT3.

Lee JJ, van de Ven RAH, Zaganjor E, Ng MR, Barakat A, Demmers JJPG, Finley LWS, Gonzalez Herrera KN, Hung YP, Harris IS, Jeong SM, Danuser G, McAllister SS, Haigis MC.

Proc Natl Acad Sci U S A. 2018 Jul 3;115(27):7057-7062. doi: 10.1073/pnas.1800440115. Epub 2018 Jun 18.

5.

Accounting for tumor heterogeneity when using CRISPR-Cas9 for cancer progression and drug sensitivity studies.

Olive JF, Qin Y, DeCristo MJ, Laszewski T, Greathouse F, McAllister SS.

PLoS One. 2018 Jun 13;13(6):e0198790. doi: 10.1371/journal.pone.0198790. eCollection 2018.

6.

CDK4/6 inhibition triggers anti-tumour immunity.

Goel S, DeCristo MJ, Watt AC, BrinJones H, Sceneay J, Li BB, Khan N, Ubellacker JM, Xie S, Metzger-Filho O, Hoog J, Ellis MJ, Ma CX, Ramm S, Krop IE, Winer EP, Roberts TM, Kim HJ, McAllister SS, Zhao JJ.

Nature. 2017 Aug 24;548(7668):471-475. doi: 10.1038/nature23465. Epub 2017 Aug 16.

7.

The skinny on obesity and cancer.

Sceneay J, McAllister SS.

Nat Cell Biol. 2017 Jul 28;19(8):887-888. doi: 10.1038/ncb3583.

PMID:
28752848
8.

Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells.

Ubellacker JM, Haider MT, DeCristo MJ, Allocca G, Brown NJ, Silver DP, Holen I, McAllister SS.

Breast Cancer Res. 2017 Mar 6;19(1):23. doi: 10.1186/s13058-017-0815-8.

9.

Loss of RasGAP Tumor Suppressors Underlies the Aggressive Nature of Luminal B Breast Cancers.

Olsen SN, Wronski A, Castaño Z, Dake B, Malone C, De Raedt T, Enos M, DeRose YS, Zhou W, Guerra S, Loda M, Welm A, Partridge AH, McAllister SS, Kuperwasser C, Cichowski K.

Cancer Discov. 2017 Feb;7(2):202-217. doi: 10.1158/2159-8290.CD-16-0520. Epub 2016 Dec 14.

10.

Aspirin Suppresses Growth in PI3K-Mutant Breast Cancer by Activating AMPK and Inhibiting mTORC1 Signaling.

Henry WS, Laszewski T, Tsang T, Beca F, Beck AH, McAllister SS, Toker A.

Cancer Res. 2017 Feb 1;77(3):790-801. doi: 10.1158/0008-5472.CAN-16-2400. Epub 2016 Dec 9.

11.

The unresolved role of systemic factors in bone metastasis.

Ubellacker JM, McAllister SS.

J Bone Oncol. 2016 May 16;5(3):96-99. eCollection 2016 Sep.

12.

Hematopoietic Age at Onset of Triple-Negative Breast Cancer Dictates Disease Aggressiveness and Progression.

Marsh T, Wong I, Sceneay J, Barakat A, Qin Y, Sjödin A, Alspach E, Nilsson B, Stewart SA, McAllister SS.

Cancer Res. 2016 May 15;76(10):2932-43. doi: 10.1158/0008-5472.CAN-15-3332. Epub 2016 Apr 7.

13.

Role of buoyant flame dynamics in wildfire spread.

Finney MA, Cohen JD, Forthofer JM, McAllister SS, Gollner MJ, Gorham DJ, Saito K, Akafuah NK, Adam BA, English JD.

Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):9833-8. doi: 10.1073/pnas.1504498112. Epub 2015 Jul 16.

14.

The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis.

McAllister SS, Weinberg RA.

Nat Cell Biol. 2014 Aug;16(8):717-27. doi: 10.1038/ncb3015. Review.

PMID:
25082194
15.

SPSB1 may have MET its match during breast cancer recurrence.

Qin Y, McAllister SS.

Cancer Discov. 2014 Jul;4(7):760-1. doi: 10.1158/2159-8290.CD-14-0505.

16.

p38MAPK plays a crucial role in stromal-mediated tumorigenesis.

Alspach E, Flanagan KC, Luo X, Ruhland MK, Huang H, Pazolli E, Donlin MJ, Marsh T, Piwnica-Worms D, Monahan J, Novack DV, McAllister SS, Stewart SA.

Cancer Discov. 2014 Jun;4(6):716-29. doi: 10.1158/2159-8290.CD-13-0743. Epub 2014 Mar 26.

17.

Breast cancer as a systemic disease: a view of metastasis.

Redig AJ, McAllister SS.

J Intern Med. 2013 Aug;274(2):113-26. doi: 10.1111/joim.12084. Review.

18.

Stromal EGF and igf-I together modulate plasticity of disseminated triple-negative breast tumors.

Castaño Z, Marsh T, Tadipatri R, Kuznetsov HS, Al-Shahrour F, Paktinat M, Greene-Colozzi A, Nilsson B, Richardson AL, McAllister SS.

Cancer Discov. 2013 Aug;3(8):922-35. doi: 10.1158/2159-8290.CD-13-0041. Epub 2013 May 20.

19.

Fibroblasts as architects of cancer pathogenesis.

Marsh T, Pietras K, McAllister SS.

Biochim Biophys Acta. 2013 Jul;1832(7):1070-8. doi: 10.1016/j.bbadis.2012.10.013. Epub 2012 Oct 30. Review.

20.

Identification of luminal breast cancers that establish a tumor-supportive macroenvironment defined by proangiogenic platelets and bone marrow-derived cells.

Kuznetsov HS, Marsh T, Markens BA, Castaño Z, Greene-Colozzi A, Hay SA, Brown VE, Richardson AL, Signoretti S, Battinelli EM, McAllister SS.

Cancer Discov. 2012 Dec;2(12):1150-65. doi: 10.1158/2159-8290.CD-12-0216. Epub 2012 Aug 15.

21.

Got a light? Illuminating lung cancer.

McAllister SS.

Sci Transl Med. 2012 Jul 11;4(142):142fs22. doi: 10.1126/scitranslmed.3004446.

PMID:
22786678
22.

The bed and the bugs: interactions between the tumor microenvironment and cancer stem cells.

Castaño Z, Fillmore CM, Kim CF, McAllister SS.

Semin Cancer Biol. 2012 Oct;22(5-6):462-70. doi: 10.1016/j.semcancer.2012.04.006. Epub 2012 Apr 23. Review.

23.

The tumor macroenvironment and systemic regulation of breast cancer progression.

Castaño Z, Tracy K, McAllister SS.

Int J Dev Biol. 2011;55(7-9):889-97. doi: 10.1387/ijdb.113366zc. Review.

24.

Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice.

Elkabets M, Gifford AM, Scheel C, Nilsson B, Reinhardt F, Bray MA, Carpenter AE, Jirström K, Magnusson K, Ebert BL, Pontén F, Weinberg RA, McAllister SS.

J Clin Invest. 2011 Feb;121(2):784-99. doi: 10.1172/JCI43757. Epub 2011 Jan 25.

25.

Tumor-host interactions: a far-reaching relationship.

McAllister SS, Weinberg RA.

J Clin Oncol. 2010 Sep 10;28(26):4022-8. doi: 10.1200/JCO.2010.28.4257. Epub 2010 Jul 19. Review.

PMID:
20644094
26.

Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression.

Godar S, Ince TA, Bell GW, Feldser D, Donaher JL, Bergh J, Liu A, Miu K, Watnick RS, Reinhardt F, McAllister SS, Jacks T, Weinberg RA.

Cell. 2008 Jul 11;134(1):62-73. doi: 10.1016/j.cell.2008.06.006.

27.

Systemic endocrine instigation of indolent tumor growth requires osteopontin.

McAllister SS, Gifford AM, Greiner AL, Kelleher SP, Saelzler MP, Ince TA, Reinhardt F, Harris LN, Hylander BL, Repasky EA, Weinberg RA.

Cell. 2008 Jun 13;133(6):994-1005. doi: 10.1016/j.cell.2008.04.045.

28.

Novel p27(kip1) C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions.

McAllister SS, Becker-Hapak M, Pintucci G, Pagano M, Dowdy SF.

Mol Cell Biol. 2003 Jan;23(1):216-28.

29.

TAT-mediated protein transduction into mammalian cells.

Becker-Hapak M, McAllister SS, Dowdy SF.

Methods. 2001 Jul;24(3):247-56. Review.

PMID:
11403574

Supplemental Content

Loading ...
Support Center